Charlie Strange to Molecular Targeted Therapy
This is a "connection" page, showing publications Charlie Strange has written about Molecular Targeted Therapy.
Connection Strength
0.135
-
Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease. Eur Respir Rev. 2017 Dec 31; 26(146).
Score: 0.135
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.